How Many Patients Will Benefit From a New Therapy for Chronic Systolic Heart Failure, and What Difference Does it Make?

被引：2
|
作者：
Borer, Jeffrey S. [1 ,2 ,3 ,4 ]
机构：
[1] Suny Downstate Med Ctr, Howard Gilman Inst Heart Valve Dis, Div Cardiovasc Med, Brooklyn, NY 11203 USA
[2] Suny Downstate Med Ctr, Schiavone Inst Cardiovasc Translat Res, Brooklyn, NY 11203 USA
[3] Suny Downstate Med Ctr, Howard Gilman Inst Heart Valve Dis, Div Cardiovasc Med, New York, NY 10128 USA
[4] Suny Downstate Med Ctr, Schiavone Inst Cardiovasc Translat Res, New York, NY 10128 USA
来源：
JACC-HEART FAILURE | 2015年 / 3卷 / 03期
关键词：
f-channels; heart rate reduction; myocardial function; RATE REDUCTION; OUTCOMES; SHIFT; ASSOCIATION; IVABRADINE; FORCE; CARE;
D O I：
10.1016/j.jchf.2014.12.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：231 / 233
页数：3
相关论文
共 50 条
  • [31] How does cardiac resynchronization therapy improve exercise capacity in chronic heart failure?
    Middlekauff, HR
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (07) : 534 - 541
  • [32] Heart failure: How big is the problem? Who are the patients? What does the future hold?
    Ansari, M
    Massie, BM
    AMERICAN HEART JOURNAL, 2003, 146 (01) : 1 - 4
  • [33] Initial Therapy Does Not Substantially Improve Dyspnea in Many ER Acute Heart Failure Patients
    Sauser, Kori
    Collins, Sean
    Hollander, Judd
    Storrow, Alan
    Nowak, Richard
    Andrei, Adin-Cristian
    Miller, Chad
    Peacock, Frank
    Tavares, Miguel
    Mebazaa, Alexander
    Gheorghiade, Mihai
    Pang, Peter S.
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : S78 - S78
  • [34] Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
    Cioffi, G
    De Feo, S
    Pulignano, G
    Del Sindaco, D
    Tarantini, L
    Stefenelli, C
    Opasich, C
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 107 (02) : 220 - 224
  • [35] Novel therapy for chronic heart failure - Comparison of old patients and new patients
    Kenji, M
    Shinya, H
    Masatsugu, I
    Akihisa, U
    Masatsugu, O
    Shigeru, K
    Ryuji, Y
    Nami, M
    Shin-Ichiro, M
    Hitoshi, H
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (05) : S184 - S184
  • [36] The identification of heart failure patients prone to benefit from cardiac resynchronisation therapy
    Pitzalis, M. V.
    Iacoviello, M.
    Romito, R.
    De Tommasi, E.
    Guida, P.
    Luzzi, G.
    ADVANCES IN HEART DISEASE, 2006, : 547 - +
  • [37] SGLT2 INHIBITION IN HEART FAILURE WITH A REDUCED EJECTION FRACTION: HOW MANY PATIENTS WOULD BENEFIT?
    Hooper, Jacquelyn
    Shaw, Steven
    Callan, Paul
    Williams, Simon
    HEART, 2021, 107 : A115 - A115
  • [38] Implementation of evidence–based therapy in patients with systolic heart failure from 1998–2000
    Rona K. Reibis
    C. Dovifat
    R. Dissmann
    B. Ehrlich
    S. Schulz
    K. Stolze
    K. Wegscheider
    H. Völler
    Clinical Research in Cardiology, 2006, 95 : 154 - 161
  • [39] New and Emerging Drugs and Device Therapies for Chronic Heart Failure in Patients With Systolic Ventricular Dysfunction
    Rouleau, Jean L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (03) : 296 - 301
  • [40] Heart failure therapy in new onset heart failure versus chronic heart failure: an analysis of 90,383 patients from the Swedish Heart Failure Registry (SwedeHF)
    Shahim, A.
    Savarese, G.
    Dahlstrom, U.
    Lund, L. H.
    Linde, C.
    Hage, C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 943 - 943
12345